FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982904703> ?p ?o ?g. }

• W1982904703 endingPage "520" @default.
• W1982904703 startingPage "513" @default.
• W1982904703 abstract "It has long been recognized that some patients with low-grade astrocytoma may survive for many years, whereas in others the disease follows a more malignant course resulting in a short survival time, usually due to malignant transformation into higher-grade tumors. Object. The aim of this study was to investigate angiogenesis in the initial biopsy specimen of tumor tissue as a biological marker to identify patients with low-grade astrocytoma who are at high risk of malignant tumor transformation or death. Methods. Tumor tissue was studied in 74 consecutively treated adult patients in whom a diagnosis of diffuse supratentorial hemispheric histologically proven fibrillary low-grade astrocytoma was made and who underwent surgery between January 1972 and January 1994. Studies were conducted using monoclonal antibodies to the antigens of the proliferation-associated Ki-67 (MIB-1), factor VIII, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF). The overall 5-year survival rate for the entire patient population was 65%, with a median survival time of 7.5 years. The total mean follow-up period was 6.1 years. All tumors showed a low proliferative potential at the time of the initial operation, as demonstrated by an MIB-1 labeling index of less than 1.5%. Patients with more than seven microvessels in tumor tissue (29 cases) had a shorter survival time (mean 3.8 years) than those with seven or fewer microvessels (mean survival 11.2 years). This difference in survival times was significant by univariate (p = 0.001) and stepwise multivariate analyses (p < 0.001). Tumors with a larger number of microvessels also had a greater chance of undergoing malignant transformation (p = 0.001). Similarly, significant staining for VEGF was correlated with shorter survival times when using univariate (p = 0.003) and multivariate (p = 0.008) analyses and with a greater chance of malignant transformation (p = 0.002). Patients with tumors staining positive for VEGF (39 individuals) had a median survival time of 5.3 years, and those with tumors negative for VEGF (35 patients) had a median survival time of 11.2 years. No association was observed between bFGF, EGF, and survival or malignant transformation. The stepwise multivariate analysis included histological and clinical variables simultaneously. Conclusions. The authors have shown that microvessel density and VEGF levels are independent prognostic markers of survival in fibrillary low-grade astrocytoma. This finding leads them to propose that fibrillary diffuse low-grade astrocytoma is not a single pathological entity but is composed of a spectrum of tumors with differing propensities to undergo malignant transformation that is at least partly based on their inherent angiogenic potential." @default.
• W1982904703 created "2016-06-24" @default.
• W1982904703 creator A5024222984 @default.
• W1982904703 creator A5059698282 @default.
• W1982904703 creator A5069820574 @default.
• W1982904703 creator A5075254008 @default.
• W1982904703 creator A5080097716 @default.
• W1982904703 creator A5084542809 @default.
• W1982904703 date "1998-03-01" @default.
• W1982904703 modified "2023-09-27" @default.
• W1982904703 title "Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma" @default.
• W1982904703 cites W1558416993 @default.
• W1982904703 cites W1964344244 @default.
• W1982904703 cites W1969328947 @default.
• W1982904703 cites W1972512104 @default.
• W1982904703 cites W1974847420 @default.
• W1982904703 cites W1976195989 @default.
• W1982904703 cites W1978139448 @default.
• W1982904703 cites W1988605844 @default.
• W1982904703 cites W1993327996 @default.
• W1982904703 cites W1994025908 @default.
• W1982904703 cites W1994769053 @default.
• W1982904703 cites W2003357753 @default.
• W1982904703 cites W2005177011 @default.
• W1982904703 cites W2015344488 @default.
• W1982904703 cites W2018442334 @default.
• W1982904703 cites W2023462156 @default.
• W1982904703 cites W2031720250 @default.
• W1982904703 cites W2041085319 @default.
• W1982904703 cites W2046432580 @default.
• W1982904703 cites W2049063913 @default.
• W1982904703 cites W2053375897 @default.
• W1982904703 cites W2064624801 @default.
• W1982904703 cites W2071752743 @default.
• W1982904703 cites W2085277801 @default.
• W1982904703 cites W2092840321 @default.
• W1982904703 cites W2102628178 @default.
• W1982904703 cites W2109937583 @default.
• W1982904703 cites W2109996739 @default.
• W1982904703 cites W2129941826 @default.
• W1982904703 cites W2133138712 @default.
• W1982904703 cites W2319962899 @default.
• W1982904703 cites W2324677651 @default.
• W1982904703 cites W2325509426 @default.
• W1982904703 cites W2412452782 @default.
• W1982904703 cites W2611360427 @default.
• W1982904703 cites W3143360378 @default.
• W1982904703 cites W4210453240 @default.
• W1982904703 cites W4237737307 @default.
• W1982904703 cites W4240150154 @default.
• W1982904703 cites W4254499479 @default.
• W1982904703 cites W4293241248 @default.
• W1982904703 cites W4376595364 @default.
• W1982904703 cites W4376596066 @default.
• W1982904703 doi "https://doi.org/10.3171/jns.1998.88.3.0513" @default.
• W1982904703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9488306" @default.
• W1982904703 hasPublicationYear "1998" @default.
• W1982904703 type Work @default.
• W1982904703 sameAs 1982904703 @default.
• W1982904703 citedByCount "192" @default.
• W1982904703 countsByYear W19829047032012 @default.
• W1982904703 countsByYear W19829047032013 @default.
• W1982904703 countsByYear W19829047032014 @default.
• W1982904703 countsByYear W19829047032015 @default.
• W1982904703 countsByYear W19829047032016 @default.
• W1982904703 countsByYear W19829047032017 @default.
• W1982904703 countsByYear W19829047032018 @default.
• W1982904703 countsByYear W19829047032019 @default.
• W1982904703 countsByYear W19829047032020 @default.
• W1982904703 countsByYear W19829047032021 @default.
• W1982904703 countsByYear W19829047032022 @default.
• W1982904703 countsByYear W19829047032023 @default.
• W1982904703 crossrefType "journal-article" @default.
• W1982904703 hasAuthorship W1982904703A5024222984 @default.
• W1982904703 hasAuthorship W1982904703A5059698282 @default.
• W1982904703 hasAuthorship W1982904703A5069820574 @default.
• W1982904703 hasAuthorship W1982904703A5075254008 @default.
• W1982904703 hasAuthorship W1982904703A5080097716 @default.
• W1982904703 hasAuthorship W1982904703A5084542809 @default.
• W1982904703 hasConcept C126322002 @default.
• W1982904703 hasConcept C142724271 @default.
• W1982904703 hasConcept C144301174 @default.
• W1982904703 hasConcept C167734588 @default.
• W1982904703 hasConcept C170493617 @default.
• W1982904703 hasConcept C204232928 @default.
• W1982904703 hasConcept C2775934546 @default.
• W1982904703 hasConcept C2775960820 @default.
• W1982904703 hasConcept C2777025900 @default.
• W1982904703 hasConcept C2777587049 @default.
• W1982904703 hasConcept C2778227246 @default.
• W1982904703 hasConcept C2778880634 @default.
• W1982904703 hasConcept C2780394083 @default.
• W1982904703 hasConcept C2908647359 @default.
• W1982904703 hasConcept C38180746 @default.
• W1982904703 hasConcept C502942594 @default.
• W1982904703 hasConcept C71924100 @default.
• W1982904703 hasConcept C90924648 @default.
• W1982904703 hasConcept C99454951 @default.

• next